An inquiry has been initiated by the national shareholder rights firm Hagens Berman Sobol Shapiro into Medline Inc. (NASDAQ: MDLN) based in San Francisco on July 7, 2026. The investigation specifically delves into concerns about potential misinformation provided to investors concerning the effectiveness of the company's manufacturing practices.